On the heels of National Eczema Awareness Month, MotherToBaby Pregnancy Studies has launched their newest study on Dupixent® (dupilumab), an injectable medication used to treat patients with moderate to severe atopic dermatitis, the most common form of eczema. The study will provide information on the safety of Dupixent® when used during pregnancy, and will help women and their healthcare providers get the information they need to make more informed treatment decisions. The National Institute …
Press Releases
Stay Connected, Stay Current with MotherToBaby
If you’re looking for the latest news about exposures during pregnancy and breastfeeding, you’ve come to the right place! Read on for the latest press releases distributed by MotherToBaby including exposure findings, research opportunities, organization announcements, educational and professional development opportunities, and birth defects prevention campaigns.
Opioid Resources Unveiled for Pregnant and Breastfeeding Women, Health Providers
Following White House Proclamation, MotherToBaby Offers One-Stop for Latest Information about Opioid Effects on Developing Babies BRENTWOOD, TN –A series of new opioid-specific fact sheets, blogs and a recent webinar are just some of the pregnancy and breastfeeding-related resources unveiled by MotherToBaby, a service of the non-profit Organization of Teratology Information Specialists (OTIS), in response to the alarming toll opioid addiction is taking on communities from coast to coast. The …
Recording: Free Webinar on Opioid Abuse in Pregnancy and Breastfeeding
IN CASE YOU MISSED IT: Webinar Regarding Rising Opioid Abuse Trends in Developing Babies BRENTWOOD, TN –“On an almost daily basis I take care of women struggling with opioid addiction or dependency in pregnancy and the post-partum period.” Sarah Obican, MD, Maternal-Fetal Medicine Subspecialist at the University of South Florida, knows she’s not alone as the opioid epidemic rages on in America. “I actively screen patients in early pregnancy and see them on our antepartum units.” It’s a crisis …
OTIS Member Pens Passionate Op-Ed on New Postpartum Mental Illness Law
Katherine L. Wisner, MD, MS, a long time OTIS member and perinatal psychiatrist, recently co-authored an op-ed in support of a new Illinois law set to take effect this summer that will address the legal liability women have when they commit criminal acts while suffering from severe postpartum mental illness. The op-ed was published in The Hill and can be read here. The new law, a first of its kind, will highlight postpartum mental illness as a factor for judges to consider when determining an …
‘FIRST OF ITS KIND’ SERVICE LAUNCHES TO SUPPORT DRUG LABELING COMPLIANCE RULE
OTIS Offers Relief for Pharma Companies under Pressure to Update Labels with Pregnancy and Lactation Info BRENTWOOD, TN –“It’s the first service of its kind to aid pharmaceutical companies in this way,” described Stephen Braddock, MD, a St. Louis-based pediatrician and dysmorphologist in reference to a new endeavor offered by birth defects experts at the Organization of Teratology Information Specialists (OTIS). The unique offering aims to support the implementation of the FDA Pregnancy and …
